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Abstract
This review on coronary artery ectasia (CAE) explores what is currently known 
about its classification, etiology and pathogenesis, clinical manifestations, 
methods of diagnosis, treatment and prognosis. CAE is not a rare coro-
nary anomaly. Its prevalence is about 0.3–12% in autopsies and during 
coronary angiography or multidetector computed tomography (MDCT). Its 
etiology is varied and its pathophysiology is not completely understood. 
More than half of CAE cases is due to coronary atherosclerosis, and the 
right coronary artery is most commonly affected. Angina pectoris is the most 
common clinical manifestation. Unstable angina, acute myocardial infarc-
tion, heart failure, ventricular tachycardia/fibrillation, and sudden death 
have also been reported. Myocardial ischemia is possibly caused by coex-
isting significant coronary stenosis, slow flow, microvascular dysfunction, 
thrombus formation, coronary spasm or spontaneous coronary dissection. 
Coronary angiography, intravascular ultrasound, and MDCT are the current 
major diagnostic tools for CAE. The prognosis of CAE has shown improve-
ment when it is treated with aggressive medical therapy, modern revas-
cularization techniques, and state-of-the-art equipment. [Tzu Chi Med J 
2008;20(4):270–274]
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1. Introduction
Coronary artery ectasia (CAE) has been observed by 
pathologists and cardiologists for more than two cen-
turies. This coronary anomaly was first described by 
Morgagni in 1761 [1]. Bourgon was the first to describe 
the postmortem finding of right coronary artery (RCA) 
dilatation in a patient who experienced sudden death 
in 1812 [2]. The term ectasia was first used by Bjork 
in 1966 to describe dilated coronary arteries [3]. The 
lit erature prior to this date consisted of only postmor-
tem reports. Coronary angiography and new diagnostic 
tools have enabled clinicians to discover more cases 
of ectasia. However, not all patients with ectasia are 
symptomatic and receive coronary angiography exami-
nation; hence, the real incidence is unknown. The re-
ported in ci dence is between 0.3% and 4.9% at autopsy 
and during coronary angiography [4–6]. Zeina et al 
determined that the prevalence of CAE in consecu-
tive par ticipants who underwent coronary multidetec-
tor com puted to mog raphy (MDCT) was 8% [7]. Sharma 
et al found an incidence as high as 12% in an Indian 
population [8], which may have different demographic 
characteristics.
There is a male preponderance, with a male-to-
female ratio of 3:1 [5,9,10]. The proximal and mid-
dle parts of the RCA are most commonly affected by 
ectasia, although the reasons for this are not clear. 
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Involvement of the left anterior descending artery 
and left circumflex artery is variable. The left main 
coronary artery is less commonly involved. Most cases 
of CAE involve only a single vessel. Disturbance in 
blood flow filling and washout are major characteris-
tics of CAE. Delayed antegrade filling, a segmental back 
flow phenomenon, and local deposition of dye (stasis) 
in the dilated coronary segment have been observed 
during imaging [11,12].
2. Definition and classification
There are various methods for defining CAE. Hartnell 
et al defined CAE as an arterial segment with a diam-
eter at least 1.5 times the diameter of the adjacent 
normal coronary artery [6]. Markis et al provided the 
following classification of CAE based on the extent of 
coronary involvement: type I, diffuse ectasia of two or 
three vessels; type II, diffuse disease in one vessel and 
localized disease in another vessel; type III, diffuse ect-
asia of one vessel only; and type IV, localized or seg-
mental ectasia [9]. This classification is used extensively. 
Plehn et al preferred to use the term coronary artery 
aneurysm for segmental ectasia, reserving the term 
ectasia for diffuse vessel involvement [13]. They clas-
sified aneurysms as small (< 5 mm), medium (5–8 mm), 
or giant (≥ 8 mm). In addition, coronary artery aneu-
rysm has been classified as the fusiform or saccular 
type based on the anatomic shape of the ecstatic seg-
ment. There is no general concept concerning the crit-
ical diameter required for the development of rupture.
To date, only a few reports have described the 
anato mic changes that occur in CAE over time. Plehn 
et al reported a patient who presented with ectatic 
lesions that rapidly progressed to aneurysmatic le-
sions within 3 years [13]. The patient was treated with 
aneurysm ligation and coronary artery bypass graft-
ing (CABG). Periodic careful follow-up of patients with 
CAE is recommended.
3. Etiology and pathogenesis
More than 50% of CAE cases are reportedly caused 
by atherosclerosis [5,10,12]. Compensatory vessel 
enlargement in the presence of coronary atheroscle-
rotic plaques is a common phenomenon that is viewed 
as positive remodeling [14]. Progressive overcompen-
sation leading to ectasia may be caused by an inad-
equate extent of media atrophy and fracture of the 
internal elastic lamina, as well as atypical rearrange-
ment of smooth muscle cells [15,16]. Virmani et al 
provided a detailed pathologic characterization of CAE, 
including lipid deposition with foam cells, fibrous caps 
and significant loss of musculoelastic vascular wall 
components as the main histological abnormalities 
[17]. The reason why stenosis develops in some indi-
viduals with atherosclerosis while dilatation occurs in 
others is unknown. Genetic susceptibility is likely to 
explain why certain individuals are at risk of develop-
ing CAE [18,19].
Many other clinical entities can cause dilation of the 
coronary arteries, such as syphilis, mycotic or bacte-
rial infection, Kawasaki disease, trauma, congenital 
heart disease, inflammatory disorders, connective tis-
sue dis orders such as Marfan syndrome, scleroderma, 
systemic lupus, Ehlers-Danlos syndrome, periarteri-
tis nodosa, Behcet’s disease and congenital defects 
[12,20–22]. Prolonged exposure to herbicides such 
as 2,4,5-T (trichlorophenoxyacetic acid) and 2,4-D 
(dichlorophenoxyacetic acid) has been associated with 
CAE [23]. These herbicides, which contain acetylcho-
linesterase inhibitors, can increase the levels of ace-
tylcholine and stimulate the production of nitric oxide. 
Nitric oxide can stimulate relaxation of the coronary 
artery. At present, it is not known whether or not chron ic 
relaxation of the smooth muscle layer of the coronary 
artery causes CAE [24].
CAE can also be iatrogenic in origin, for example 
after percutaneous coronary intervention (PCI). Chiu 
et al reported a patient who developed coronary ar-
tery aneurysm after successful stent implantation for 
a chronic totally occluded lesion [25]. Interestingly, 
the aneurysm spontaneously regressed a few months 
later without further intervention. It was thought that 
the most likely mechanism for this was shear stress 
inducing vessel positive remodeling after an interven-
tion procedure, with subsequent negative remodeling 
when the shear stress returned to baseline.
Lamblin et al found that patients with CAE had a 
higher percentage of the 5A/5A polymorphism of 
metalloproteinase-3 (MMP-3), which is actively involved 
in the proteolysis of extracellular matrix proteins [26]. 
The levels of inflammatory markers such as plasma 
interleukin-6, C-reactive protein, V-CAM, I-CAM and 
E-selectin are elevated in CAE patients [27–30]. This 
suggests a role for the inflammatory process in this 
setting.
Pinar et al determined that CAE was associated with 
the classical cardiovascular risk factors except for 
diabetes, which was rare in patients with isolated 
CAE [31]. This negative correlation between diabetes 
and CAE has also been reported by others. Williams 
et al found impaired nitric oxide-mediated vasodila-
tation in patients with non-insulin-dependent diabetes 
[32]. However, Zeina et al demonstrated that there was 
no apparent correlation between CAE and hyperten-
sion, hyperlipidemia, diabetes, smoking and a family 
history of coronary artery disease [7]. The actual rela-
tionship between CAE and traditional cardiovascular 
risk factors still needs to be clarified by further study.
Considering all of the above findings, Manginas 
and Cokkinos speculated that CAE occurs due to two 
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different mechanisms in two distinct patient groups: 
(1) commonly in patients with concomitant coronary 
artery disease due to severe and chronic arterial in-
flammation; and (2) rarely in subjects without coro-
nary atherosclerosis as a result of exogenous interstitial 
nitric oxide vascular overestimation [12].
4. Clinical manifestations
Although it has been shown that more than half of 
patients with CAE have underlying coronary artery 
stenosis, the symptoms do not directly correlate with 
the degree of stenosis. Sayin et al postulated that 
CAE subjects patients to a higher risk of myocardial 
ischemia irrespective of the extent of stenosis [33]. 
On the contrary, the Coronary Artery Surgery Study 
database show ed no difference in 5-year survival 
for patients with both CAE and coronary artery dis-
ease compared with those with only coronary artery 
disease [5].
Angina is the most common symptom in patients 
with CAE; ST-elevation myocardial infarction, non-ST-
elevation myocardial infarction, heart failure, and se-
vere arrhythmias such as ventricular tachycardia and 
fibrillation have also been reported. Bove and Vlietstra 
demonstrated that ectatic arteries are prone to spasm 
[34]. Suzuki et al used computer analysis to evaluate 
the effects of ergonovine- and acetylcholine-induced 
spasm [35]. They found that the actual narrowing in-
duced by these agents usually occurred adjacent to 
the ectatic portion and less commonly within the ec-
tatic area. Perlman and Ridgeway documented a large, 
left anterior descending artery thrombus in a patient 
with triple vessel coronary artery ectasia [36]. Huikuri 
et al reported a case of large spontaneous dissection 
of an ectatic right coronary artery in a patient with 
out-of-hospital cardiac death [37]. Tomaru et al de-
scribed a patient who presented with sudden onset 
of shortness of breath followed by respiratory arrest, 
in whom coronary angiography showed type I CAE 
and two-vessel disease [21]. Gore et al reported a case 
of congenital coronary artery aneurysm in which the 
patient presented with dyspnea and syncope [38]. 
Tuzun et al found that stiffness parameters in the 
aorta are impaired in patients with CAE as well as in 
those with coronary artery disease [39]. The increased 
stiffness may be responsible for left ventricle diasto-
lic dysfunction, which is very important because it 
might play a key role in the development of heart 
failure. CAE has been reported to be associated with 
aortic aneurysm and patients present with abdomi-
nal pain. In a retrospective study by Stajduhar et al, 
20.8% of patients who underwent operations for ab-
dominal aneurysm had CAE [40]. Some patients with 
CAE are asymptomatic and the disease is found inci-
dentally during catheterization.
5. Diagnostic methods
Coronary angiography is now the criterion standard 
for diagnosing CAE. Coronary angiography offers a 
detailed definition of coronary anatomy, making it pos-
sible to characterize the distribution and size of cor-
onary aneurysms and also to detect coronary stenosis. 
A treadmill exercise test and thallium-201 myocar-
dial perfusion scan can be used to evaluate myocar-
dial ischemia caused by CAE. Intravascular ultrasound 
can be used to assess the luminal size and condition 
of the arterial walls, and also to differentiate true from 
false aneurysms caused by plaque rupture [41]. Mag-
netic resonance imaging has been successfully used 
to assess coronary anatomy in patients with CAE. Greil 
et al reported a small series of adolescents and young 
adults with Kawasaki disease, who were diagnosed 
by coronary magnetic resonance angiography [42]. 
MDCT is one of the newest tools used to diagnose 
CAE, and it is not invasive like coronary angiography. 
Zeina et al found a high prevalence (8%) of CAE when 
using MDCT as a diagnostic tool [7]. The first congeni-
tal CAE diagnosed by MDCT was reported by Ayusawa 
et al in 2008 [43].
6. Treatment
CAE is not a benign coronary anomaly. Sorrel et al 
suggested treating CAE patients with: (1) anticoagu-
lation therapy, utilizing chronic warfarin therapy to off-
set the risk of thrombus formation and to keep the 
international normalized ratio at around 2.0–2.5; (2) 
antiplatelet therapy, utilizing aspirin (80–360 mg/day) 
to minimize platelet aggregation; and (3) antispasm 
therapy, utilizing calcium-channel blockers [24]. Nitrates 
could also be used, but added care should be empha-
sized to provide a nitrate-free “holiday” and prevent 
chronic exposure to these agents.
Therapy should be tailored to each individual pa-
tient because of the serious bleeding complications 
associated with warfarin use. Tuncer et al reported two 
cases of CAE, one in a patient with myocardial infarc-
tion and one with unstable angina [44]. A large throm-
bus was seen in both patients and they were treated 
with aspirin, warfarin and metoprolol. One patient 
received MDCT after follow-up, which revealed that 
the thrombus had almost completely dissolved after 
3 months. Warfarin was then discontinued in both 
cases and clopidogrel was given. But these treatment 
strategies have not been studied prospectively. Heparin 
and thrombolytic therapy have been successfully 
used for recanalization. For patients with coexisting 
obstructive lesions and refractory angina despite med-
ical treatment, PCI can be performed. But there can 
be difficulties during stent deployment because the 
ectatic arteries are usually much larger than normal 
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arteries. Selection of a stent of adequate size and its 
expansion are very important, and can be determined 
by intravascular ultrasound. Rha et al reported a chal-
lenging case of implantation of two 3.5 ˜  18 sirolimus-
eluting stents parallel to each other in a large ectatic 
coronary artery [45]. They suggested that in lesions 
which have a large reference diameter, the clinician 
can consider parallel stenting using drug-eluting stents 
as a new intervention strategy. CABG has been used 
for many years for the treatment of significant coro-
nary artery disease coexisting with CAE, and the post-
operative outcome is uniformly good.
In our opinion, treatment should be tailored accord-
ing to clinical manifestations and the number and 
involvement of the coronary arteries. Medical therapy 
is recommended for patients with symptomatic non-
obstructive CAE. Surgery (CABG, aneurysm ligation, or 
aneurysmorrhectomy) is a better choice for patients 
who are refractory to coronary medical therapy and 
not suited for PCI.
7. Prognosis
There are different opinions about the prognosis of 
CAE [9,46–48]. Markis et al reported an annual mor-
tality rate of 15% during a mean follow-up period of 
24 months [9]. Baman et al reported a significant 
adverse outcome among the 276 CAE patients they 
studied, with a 5-year mortality rate of 29.1% [47]. 
Recently, because the techniques and equipment for 
revascularization have significantly improved, the prog-
nosis of CAE seems to be better. Valente et al reported 
that the prognosis of CAE was good with a low mortal-
ity rate (2%) [48], possibly because their patients with 
ST-elevated myocardial infarction and acute coronary 
syndrome all underwent PCI and the most severe cases 
with coexisting coronary stenosis underwent CABG.
8. Conclusion
CAE is worth closer study, as the different etiologies 
and complicated pathophysiology are still not com-
pletely understood. With the use of different modern 
treatment strategies, the prognosis seems to be im-
proving gradually. But these therapeutic modalities 
need large-scale, randomized, controlled studies to 
prove their long-term effectiveness.
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